Personalized drug combination testing service for cancer patients.
Labcyte Inc. and Notable Labs today announced a collaboration to apply the unique capabilities of Labcyte’s revolutionary Echo® acoustic liquid handling technology to screen individual cancer patients’ tumor cells.
Notable Labs is building on the idea of personalized medicine and using a patient’s own cancer cells to guide therapy.
Prior to starting Notable Labs, Peter worked for Tesla Motors and Morgan Stanley. He graduated from Princeton University in 2007.
Prior to founding Notable Labs, Matthew worked as an analyst in Trading and Research at Thiel Macro, as well as at Bank of America. He graduated with a Bachelor of Science in Applied Economics and Management from Cornell University.